Table 1.
Demographic data of patients
| Age (years) | Sex | Duration of disease (years) | Involvement | Smoking | CDAI | P-CRP (mg L−1) | F-calprotectin (mg kg−1) | IBD-related drugs |
|---|---|---|---|---|---|---|---|---|
| 24 | F | 1 | Ileocolonic | Yes | 194 | 37.7 | 1233 | Bud |
| 25 | F | 12 | Ileocecal | No | 128 | 14.4 | 90 | AZA |
| 31 | F | 1 | Ileocolonic | No | 62 | 10.2 | 973 | 5-ASA |
| 42 | F | 8 | Ileocolonic | No | 192 | 2.7 | 30 | Pred/5-ASA |
| 44 | F | 1 | Oesophagus to rectum | Yes | 317 | 5.6 | 1303 | |
| 23 | M | 0.5 | Ileal and rectal | No | 356 | 16.6 | 1705 | Bud |
| 27 | M | 0.5 | Ileocolonic | Yes | 115 | 7.5 | 251 | |
| 33 | M | 15 | Ileocolonic | No | 326 | 6.8 | 1180 | |
| 35 | M | 1 | Ileal | No | 22 | 5.7 | 494 | Bud |
| 40 | M | 8 | Ileal | Yes | 49 | 10.1 | 266 |
Abbreviations: 5-ASA, 5-aminosalicylate; AZA, azathioprine; Bud, budesonide; CDAI, Crohn's disease activity index; CRP, C-reactive protein; IBD, inflammatory bowel disease; Pred, prednisolone.